ESC 365 - Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

ESC Premium Access

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Session: Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Topic: Epidemiology

Speaker: Doctor I. Hammami (Oxford, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Imen Hammami

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

0 follower

12 more presentations in this session

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Speaker: Doctor A. Conti (Massa, IT)

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Speaker: Doctor A. Baluja (Santiago de Compostela, ES)

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Speaker: Doctor A. Katbeh (Aalst, BE)

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Speaker: Professor D. Linz (Maastricht, NL)

Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

Speaker: Associate Professor M. Proietti (Milan, IT)

Access the full session

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Speakers: Doctor I. Hammami, Doctor A. Conti, Doctor A. Baluja, Doctor A. Katbeh, Professor D. Linz...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources